0001209191-18-038073.txt : 20180615
0001209191-18-038073.hdr.sgml : 20180615
20180615163234
ACCESSION NUMBER: 0001209191-18-038073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180615
DATE AS OF CHANGE: 20180615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaPlaca Anthony
CENTRAL INDEX KEY: 0001453022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 18902606
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-14
0
0000742112
INVACARE CORP
IVC
0001453022
LaPlaca Anthony
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Sr. VP and General Counsel
Common Shares
2018-06-14
4
M
0
20000
16.55
A
64385
D
Common Shares
2018-06-14
4
S
0
20000
19.591
D
44385
D
Employee Stock Option (Right to Buy)
16.55
2018-06-14
4
M
0
20000
0.00
D
2018-10-27
Common Shares
20000
66700
D
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.507 - $19.675. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option vested equally on September 30, 2009, 2010, 2011 and 2012.
The reporting person holds previously reported options to buy 66,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 19, 2009 and March 18, 2013, at exercise prices between $13.37 to $25.24 per share, will expire between August 19, 2019 and March 18, 2023, and became exercisable between September 30, 2010 and March 31, 2017.
/s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission
2018-06-15